NovaBay Pharmaceuticals Urges Shareholder Vote

TL;DR

NovaBay needs your vote NOW - don't miss out!

AI Summary

NovaBay Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on November 13, 2024, related to its proxy statement. The filing indicates that no fee was required for this submission, and it is marked as "YOUR VOTE IS VERY IMPORTANT". The company is urging shareholders to vote before it is too late.

Why It Matters

This filing is important for shareholders as it highlights the company's call to action for voting, emphasizing the significance of their participation in corporate decisions.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement supplement and does not contain new material financial or operational information that would inherently increase risk.

Key Players & Entities

• NovaBay Pharmaceuticals, Inc. (company) — Registrant
• 0001437749-24-034966 (filing_id) — Accession Number
• November 13, 2024 (date) — Filing Date

FAQ

Filing Documents

• nby20241113_defa14a.htm (DEFA14A) — 15KB
• jh.jpg (GRAPHIC) — 2KB
• logo01.jpg (GRAPHIC) — 16KB
• 0001437749-24-034966.txt ( ) — 41KB

From the Filing

nby20241113_defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 NOVABAY PHARMACEUTICALS, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 **** YOUR VOTE IS VERY IMPORTANT **** VOTE NOW BEFORE IT IS TOO LATE! November 13, 2024 Dear Fellow NovaBay Shareholder, The NovaBay Pharmaceuticals, Inc. Special Meeting of Stockholders is fast approaching on November 22, 2024. Your vote is VERY important! The company urges you to submit your VOTE today! Even if you plan to attend the special meeting, we urge you to vote now so your shares can be tabulated prior to the meeting. The fastest and easiest way to vote is by telephone or online . Instructions on how to vote your shares by telephone or online are enclosed with this letter. Alternatively, you may sign and return the enclosed voting form in the envelope provided. Please note that if you own shares of NovaBay Pharmaceuticals, Inc. stock in multiple accounts, you may receive multiple packages. These are not duplicates. Please be sure to vote all your shares in all accounts. If you have questions or need help voting your shares, please call our proxy solicitation firm, Sodali & Co., at 1-800-607-0088 Thank you for your investment in NovaBay Pharmaceuticals, Inc. and for taking the time to vote your shares. Very truly yours, Justin M. Hall, Esq. Chief Executive Officer jhall@novabay.com NOVABAY PHARMACEUTICALS, INC. 2000 Powell St, Suite 1150, Emeryville, CA 94608 Phone: (510) 899-8870 Fax: (510) 255-0371

View Full Filing

View this DEFA14A filing on SEC EDGAR